Cargando...

Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials

Because the human heart has limited potential for regeneration, the loss of cardiomyocytes during cardiac myopathy and ischaemic injury can result in heart failure and death. Stem cell therapy has emerged as a promising strategy for the treatment of dead myocardium, directly or indirectly, and seems...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Anal Cell Pathol (Amst)
Autores principales: Hao, Ming, Wang, Richard, Wang, Wen
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282433/
https://ncbi.nlm.nih.gov/pubmed/28194324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9404057
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!